• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Immunogenicity of a vaccine regimen composed of simian immunodeficiency virus DNA, rMVA, and viral particles administered to female rhesus macaques via four different mucosal routes.四种不同黏膜途径给予雌性恒河猴的猴免疫缺陷病毒 DNA、rMVA 和病毒颗粒疫苗方案的免疫原性。
J Virol. 2013 Apr;87(8):4738-50. doi: 10.1128/JVI.03531-12. Epub 2013 Feb 13.
2
CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge.CD40L佐剂化DNA/改良安卡拉痘苗病毒猿猴免疫缺陷病毒SIV239疫苗可增强SIV特异性体液免疫和细胞免疫,并提高对异源SIVE660黏膜攻击的保护作用。
J Virol. 2014 Sep 1;88(17):9579-89. doi: 10.1128/JVI.00975-14. Epub 2014 Jun 11.
3
Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques.展示三聚体猴免疫缺陷病毒(SIV)包膜糖蛋白160的病毒样颗粒增强了恒河猴中DNA/改良痘苗病毒安卡拉SIV疫苗诱导的抗体反应的广度。
J Virol. 2016 Sep 12;90(19):8842-54. doi: 10.1128/JVI.01163-16. Print 2016 Oct 1.
4
Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques.用减毒活疫苗NYVAC/猴免疫缺陷病毒SIV(gpe)重组疫苗进行黏膜免疫和全身免疫,均可在猕猴的黏膜组织中引发针对gag的CD8(+) T细胞应答。
J Virol. 2002 Nov;76(22):11659-76. doi: 10.1128/jvi.76.22.11659-11676.2002.
5
Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV.病毒载体、初免-加强 SIV 疫苗方案在婴儿恒河猴中的免疫原性:减毒水疱性口炎病毒(VSV)和改良安卡拉痘苗病毒(MVA)重组 SIV 疫苗与活减毒 SIV 相比。
Vaccine. 2010 Feb 10;28(6):1481-92. doi: 10.1016/j.vaccine.2009.11.061. Epub 2009 Dec 6.
6
Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251.用全灭活猴免疫缺陷病毒(SIV)或包膜及核心亚单位抗原疫苗进行靶向淋巴结免疫,不能可靠地保护恒河猴免受SIVmac251的阴道攻击。
AIDS. 1998 Jan 1;12(1):1-10. doi: 10.1097/00002030-199801000-00001.
7
Long-term control of simian immunodeficiency virus mac251 viremia to undetectable levels in half of infected female rhesus macaques nasally vaccinated with simian immunodeficiency virus DNA/recombinant modified vaccinia virus Ankara.经鼻腔接种猴免疫缺陷病毒 DNA/重组改良安卡拉痘苗病毒的感染雌性恒河猴中,有一半可将猴免疫缺陷病毒 mac251 病毒血症长期控制在无法检测的水平。
J Immunol. 2011 Mar 15;186(6):3581-93. doi: 10.4049/jimmunol.1002594. Epub 2011 Feb 11.
8
Vaccine-Elicited Mucosal and Systemic Antibody Responses Are Associated with Reduced Simian Immunodeficiency Viremia in Infant Rhesus Macaques.疫苗引发的黏膜和全身抗体反应与恒河猴幼猴体内猿猴免疫缺陷病毒血症的降低有关。
J Virol. 2016 Jul 27;90(16):7285-7302. doi: 10.1128/JVI.00481-16. Print 2016 Aug 15.
9
Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates.非人灵长类动物经白细胞介素-2增强的DNA修饰安卡拉痘苗病毒鼻腔接种后猿猴/人类免疫缺陷病毒血症及疾病进展的控制
J Immunol. 2004 Mar 15;172(6):3745-57. doi: 10.4049/jimmunol.172.6.3745.
10
Partial efficacy of a VSV-SIV/MVA-SIV vaccine regimen against oral SIV challenge in infant macaques.针对婴儿恒河猴口服 SIV 挑战的 VSV-SIV/MVA-SIV 疫苗方案的部分疗效。
Vaccine. 2011 Apr 12;29(17):3124-37. doi: 10.1016/j.vaccine.2011.02.051. Epub 2011 Mar 4.

引用本文的文献

1
Invaplex functions as an intranasal adjuvant for subunit and DNA vaccines co-delivered in the nasal cavity of nonhuman primates.Invaplex作为一种鼻内佐剂,用于在非人灵长类动物鼻腔中共同递送的亚单位疫苗和DNA疫苗。
Vaccine X. 2021 Jun 24;8:100105. doi: 10.1016/j.jvacx.2021.100105. eCollection 2021 Aug.
2
Oral Vaccination Approaches for Anti-SHIV Immunity.口服疫苗接种抗 HIV 免疫方法。
Front Immunol. 2021 Jun 21;12:702705. doi: 10.3389/fimmu.2021.702705. eCollection 2021.
3
Demystifying particle-based oral vaccines.解析基于粒子的口服疫苗。
Expert Opin Drug Deliv. 2021 Oct;18(10):1455-1472. doi: 10.1080/17425247.2021.1946511. Epub 2021 Jul 6.
4
Comparative Evaluation of Prophylactic SIV Vaccination Modalities Administered to the Oral Cavity.口腔途径预防性 SIV 疫苗接种方式的比较评估。
AIDS Res Hum Retroviruses. 2020 Dec;36(12):984-997. doi: 10.1089/AID.2020.0157. Epub 2020 Oct 27.
5
Mucosal Vaccine Approaches for Prevention of HIV and SIV Transmission.预防HIV和SIV传播的黏膜疫苗方法
Curr Immunol Rev. 2019;15(1):102-122. doi: 10.2174/1573395514666180605092054.
6
HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challenge.经无针口腔注射的 HIV-1 疫苗接种可诱导强烈的黏膜免疫,并可预防 SHIV 攻击。
Nat Commun. 2019 Feb 18;10(1):798. doi: 10.1038/s41467-019-08739-4.
7
Oral Coadministration of an Intramuscular DNA/Modified Vaccinia Ankara Vaccine for Simian Immunodeficiency Virus Is Associated with Better Control of Infection in Orally Exposed Infant Macaques.口服肌肉注射型DNA/改良安卡拉痘苗病毒疫苗用于猿猴免疫缺陷病毒,与口服暴露的幼猴感染得到更好控制相关。
AIDS Res Hum Retroviruses. 2019 Mar;35(3):310-325. doi: 10.1089/AID.2018.0180. Epub 2018 Nov 27.
8
A simultaneous oral and intramuscular prime/sublingual boost with a DNA/Modified Vaccinia Ankara viral vector-based vaccine induces simian immunodeficiency virus-specific systemic and mucosal immune responses in juvenile rhesus macaques.使用基于DNA/改良痘苗病毒安卡拉病毒载体的疫苗进行口服和肌肉注射同时初免/舌下加强免疫,可在幼年恒河猴中诱导猿猴免疫缺陷病毒特异性的全身和黏膜免疫反应。
J Med Primatol. 2018 Oct;47(5):288-297. doi: 10.1111/jmp.12372. Epub 2018 Sep 11.
9
DNA Vaccine-Induced Long-Lasting Cytotoxic T Cells Targeting Conserved Elements of Human Immunodeficiency Virus Gag Are Boosted Upon DNA or Recombinant Modified Vaccinia Ankara Vaccination.DNA 疫苗诱导的针对人类免疫缺陷病毒 gag 保守元件的长效细胞毒性 T 细胞在 DNA 或重组改良安卡拉痘苗接种后得到增强。
Hum Gene Ther. 2018 Sep;29(9):1029-1043. doi: 10.1089/hum.2018.065. Epub 2018 Jun 21.
10
Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.用包裹在纳米颗粒中的Toll样受体配体辅助猿猴免疫缺陷病毒疫苗可诱导持续性抗体反应并增强对TRIM5α限制型猕猴的保护。
J Virol. 2017 Jan 31;91(4). doi: 10.1128/JVI.01844-16. Print 2017 Feb 15.

本文引用的文献

1
Replicating adenovirus-simian immunodeficiency virus (SIV) recombinant priming and envelope protein boosting elicits localized, mucosal IgA immunity in rhesus macaques correlated with delayed acquisition following a repeated low-dose rectal SIV(mac251) challenge.复制型腺病毒-猴免疫缺陷病毒(SIV)重组疫苗初免和包膜蛋白加强免疫可引起恒河猴局部黏膜 IgA 免疫,与重复低剂量直肠 SIV(mac251)攻击后的延迟获得相关。
J Virol. 2012 Apr;86(8):4644-57. doi: 10.1128/JVI.06812-11. Epub 2012 Feb 15.
2
Depletion of CD4⁺ T cells abrogates post-peak decline of viremia in SIV-infected rhesus macaques.CD4⁺ T 细胞耗竭可阻止 SIV 感染恒河猴病毒血症达峰值后的下降。
J Clin Invest. 2011 Nov;121(11):4433-45. doi: 10.1172/JCI46023. Epub 2011 Oct 17.
3
Functional cure of SIVagm infection in rhesus macaques results in complete recovery of CD4+ T cells and is reverted by CD8+ cell depletion.恒河猴的 SIVagm 感染的功能性治愈导致 CD4+T 细胞的完全恢复,而 CD8+细胞耗竭会使其逆转。
PLoS Pathog. 2011 Aug;7(8):e1002170. doi: 10.1371/journal.ppat.1002170. Epub 2011 Aug 4.
4
Vaccine-elicited SIV and HIV envelope-specific IgA and IgG memory B cells in rhesus macaque peripheral blood correlate with functional antibody responses and reduced viremia.在恒河猴外周血中,疫苗诱导的 SIV 和 HIV 包膜特异性 IgA 和 IgG 记忆 B 细胞与功能性抗体反应和降低病毒血症相关。
Vaccine. 2011 Apr 12;29(17):3310-9. doi: 10.1016/j.vaccine.2011.02.066. Epub 2011 Mar 5.
5
Long-term control of simian immunodeficiency virus mac251 viremia to undetectable levels in half of infected female rhesus macaques nasally vaccinated with simian immunodeficiency virus DNA/recombinant modified vaccinia virus Ankara.经鼻腔接种猴免疫缺陷病毒 DNA/重组改良安卡拉痘苗病毒的感染雌性恒河猴中,有一半可将猴免疫缺陷病毒 mac251 病毒血症长期控制在无法检测的水平。
J Immunol. 2011 Mar 15;186(6):3581-93. doi: 10.4049/jimmunol.1002594. Epub 2011 Feb 11.
6
Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges.免疫接种 HIV-1 gp41 亚单位病毒体诱导粘膜抗体,保护非人类灵长类动物免受阴道 SHIV 挑战。
Immunity. 2011 Feb 25;34(2):269-80. doi: 10.1016/j.immuni.2011.01.015.
7
SPICE: exploration and analysis of post-cytometric complex multivariate datasets.SPICE:用于分析和探索细胞后多维复杂数据集的工具。
Cytometry A. 2011 Feb;79(2):167-74. doi: 10.1002/cyto.a.21015. Epub 2011 Jan 7.
8
Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues.黏膜免疫途径优化:将免疫靶向至正确的组织。
Curr Top Microbiol Immunol. 2012;354:1-18. doi: 10.1007/82_2010_112.
9
Disruption of intestinal CD4+ T cell homeostasis is a key marker of systemic CD4+ T cell activation in HIV-infected individuals.肠道 CD4+T 细胞的稳态破坏是 HIV 感染个体全身 CD4+T 细胞活化的一个关键标志物。
J Immunol. 2010 Nov 1;185(9):5169-79. doi: 10.4049/jimmunol.1001801. Epub 2010 Oct 1.
10
Safety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers.Shigella flexneri 2a Invaplex 50 鼻内疫苗在成年志愿者中的安全性和免疫原性。
Vaccine. 2010 Aug 23;28(37):6076-85. doi: 10.1016/j.vaccine.2010.06.086. Epub 2010 Jul 7.

四种不同黏膜途径给予雌性恒河猴的猴免疫缺陷病毒 DNA、rMVA 和病毒颗粒疫苗方案的免疫原性。

Immunogenicity of a vaccine regimen composed of simian immunodeficiency virus DNA, rMVA, and viral particles administered to female rhesus macaques via four different mucosal routes.

机构信息

Department of Medicine, Children's Hospital, Boston, Massachusetts, USA.

出版信息

J Virol. 2013 Apr;87(8):4738-50. doi: 10.1128/JVI.03531-12. Epub 2013 Feb 13.

DOI:10.1128/JVI.03531-12
PMID:23408627
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3624383/
Abstract

A comparative evaluation of the immunity stimulated with a vaccine regimen that includes simian immunodeficiency virus (SIV), interleukin 2 (IL-2), and IL-15 DNAs, recombinant modified vaccinia virus Ankara (rMVA), and inactivated SIVmac239 particles administered into the oral and nasal cavities, small intestine, and vagina was carried out in female rhesus macaques to determine the best route to induce diverse anti-SIV immunity that may be critical to protection from SIV infection and disease. All four immunizations generated mucosal SIV-specific IgA. Oral immunization was as effective as vaginal immunization in inducing SIV-specific IgA in vaginal secretions and generated greater IgA responses in rectal secretions and saliva samples compared to the other immunization routes. All four immunizations stimulated systemic T-cell responses against Gag and Env, albeit to a different extent, with oral immunization providing greater magnitude and nasal immunization providing wider functional heterogeneity. SIV-specific T cells producing gamma interferon (IFN-γ) dominated these responses. Limited levels of SIV-specific IgG antibodies were detected in plasma samples, and no SIV-specific IgG antibodies were detected in secretions. Vaccination also induced CD4(+) and CD8(+) T-cell responses in the rectal and vaginal mucosa with greater functional heterogeneity than in blood samples. Rectal T-cell responses were significantly greater in the orally vaccinated animals than in the other animals. The most balanced, diverse, and higher-magnitude vaginal T-cell responses were observed after intestinal vaccination. Significantly higher CD8(+) granzyme B-positive T-cell responses were observed systemically after intestinal vaccination and in rectal cells after oral immunization. The majority of SIV-specific T cells that produced granzyme B did not produce cytokines. Of the immunization routes tested, oral vaccination provided the most diverse and significant response to the vaccine.

摘要

在雌性恒河猴中进行了一项研究,评估了包括猴免疫缺陷病毒(SIV)、白细胞介素 2(IL-2)、白细胞介素 15 (IL-15)DNA、重组改良安卡拉痘苗病毒(rMVA)和失活的 SIVmac239 颗粒的疫苗方案刺激的免疫反应,这些疫苗通过口腔和鼻腔、小肠和阴道接种。该研究旨在确定诱导多样化的抗 SIV 免疫反应的最佳途径,这种免疫反应对于预防 SIV 感染和疾病可能至关重要。所有四种免疫接种都产生了黏膜 SIV 特异性 IgA。与其他免疫途径相比,口腔免疫接种在诱导阴道分泌物中的 SIV 特异性 IgA 方面与阴道免疫接种同样有效,并在直肠分泌物和唾液样本中产生了更大的 IgA 反应。所有四种免疫接种都刺激了针对 Gag 和 Env 的系统 T 细胞反应,尽管程度不同,口腔免疫接种提供了更大的幅度,而鼻腔免疫接种提供了更广泛的功能异质性。产生伽马干扰素(IFN-γ)的 SIV 特异性 T 细胞主导了这些反应。在血浆样本中检测到有限水平的 SIV 特异性 IgG 抗体,在分泌物中未检测到 SIV 特异性 IgG 抗体。疫苗接种还诱导了直肠和阴道黏膜中的 CD4(+)和 CD8(+) T 细胞反应,其功能异质性大于血液样本。与其他动物相比,经口接种的动物的直肠 T 细胞反应显著更高。肠道接种后观察到最平衡、多样化和高幅度的阴道 T 细胞反应。肠道接种后系统性地观察到更高的 CD8(+)颗粒酶 B 阳性 T 细胞反应,而口腔免疫接种后直肠细胞中观察到更高的 CD8(+)颗粒酶 B 阳性 T 细胞反应。产生颗粒酶 B 的大多数 SIV 特异性 T 细胞不产生细胞因子。在测试的免疫途径中,口服接种提供了对疫苗的最多样化和最显著的反应。